U

United Therapeutics Corporation

Biotech company develops PAH therapies

Director DPF Operations

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeChristiansburg, VA, USA$171.5k - $210k /yr

About the Job

Requirements

  • A bachelor's degree in life science, engineering, or another related field and at least 15 years of experience in biologics pharmaceuticals, swine production, or biomedical animal facility operations, with demonstrated responsibility for quality, compliance, and operational performance; or a master's degree in those fields and at least 13 years of such experience.
  • At least 8 years of people management experience.
  • Experience leading teams in a GMP pharmaceutical or biotech production facility, or in swine production or biomedical animal operations with rigorous biosecurity, documented procedures, training, and audit requirements.
  • Experience supporting inspections or audits and addressing findings in a regulated production or animal-care environment.
  • Strong knowledge and demonstrated application of quality systems, procedural compliance, controlled documentation, investigation of operational issues, and corrective actions.
  • Experience leading collaboration across cross-functional teams.
  • Education, experience, and documented results in leadership and project management.
  • Experience in problem solving, negotiations, presentation, and collaborative team-building with non-direct reports across multiple geographies and cultures, as well as external parties.
  • Proficiency with the Microsoft Office software suite.

Responsibilities

  • Direct and oversee all DPF site operations, ensuring adherence to regulatory requirements and quality standards.
  • Plan, direct, and set goals for the department/function in alignment with company milestones, and support the function's overall strategy.
  • Organize and lead projects that drive quality and compliance at the site.
  • Establish necessary policies, practices, and programs for the site, and review and approve site validation documents for compliance and accuracy.
  • Manage the site budget and expenses and ensure efficient resource allocation.
  • Chair site Institutional Animal Care and Use Committee (IACUC) meetings to ensure ethical and regulatory compliance in animal care and use.
  • Author, review, and approve quality events, including change controls and deviations.
  • Lead safety initiatives at the site to maintain a secure and compliant working environment.
  • Collaborate with Quality and Regulatory teams to ensure continuous compliance with GMP and other regulatory standards.
  • Cultivate and maintain external relationships with third-party suppliers and partners, key customers, and professional organizations.
  • Lead and ensure collaboration of a cross-functional team to achieve project milestones on target.
  • Foster a culture of collaboration, quality, compliance, right-the-first-time execution, and continuous improvement at the site.
  • Collaborate with other DPF sites to help ensure a unified operational approach across sites.
  • Interact with regulatory authorities during facility inspections.
  • Direct and manage direct reports, including training, goal setting and achievement, performance evaluations and management, coaching, mentoring, career development, and supporting recruitment as needed.

Desired Qualifications

  • A master's degree in life science, engineering, or another related field.
  • Direct FDA or international health-authority inspection experience.
  • Strong knowledge of current Good Manufacturing Practices (cGMP) and experience applying pharmaceutical quality systems.
  • Experience and understanding of xenotransplantation and/or organ transplantation.

About the Company

United Therapeutics Corporation

Biotech company develops PAH therapies

United Therapeutics develops medicines for pulmonary arterial hypertension and other rare diseases, and pursues organ manufacturing through its Xenotransplantation efforts. Its drugs are given as oral tablets, intravenous infusions, or inhaled therapies to open damaged lung vessels and support heart function, while its organ programs aim to create bioengineered organs from donor animals to reduce rejection. The company differentiates itself by pairing a pharmaceutical portfolio with regenerative medicine and organ manufacturing, and by operating as a public-benefit corporation with sustainable facilities. Its goal is to end the organ transplant shortage by supplying transplantable organs while improving patient outcomes through better drug delivery and regenerative medicine.

Company size
Not listed
Company stage
IPO
Headquarters
Silver Spring, MD
Founded
1996

Recently Posted Jobs

Explore more opportunities at United Therapeutics Corporation

See more jobs